ME-13 LOSS OF SOCS3 IN MYELOID CELLS DELAYS TUMOR GROWTH AND PROLONGS SURVIVAL IN A SYNGENEIC MODEL OF GLIOBLASTOMA

Glioblastoma (GBM), a particularly devastating type of brain tumor, remains a challenging and difficult disease to treat. Despite aggressive therapies, patients diagnosed with GBM have a median survival of 12-16 months. On a cellular level, GBM tumors are extremely heterogeneous, consisting of resid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McFarland, Braden C., Marks, Margaret P., Rowse, Amber L., Gerigk, Magda, Walker, Phyllis M., Qin, Hongwei, Benveniste, Etty N.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218296/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou261.12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados